Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Biological or biochemical
Reexamination Certificate
2007-11-27
2007-11-27
Zeman, Mary K. (Department: 1631)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Biological or biochemical
C702S020000, C703S011000, C707S793000, C435S007100
Reexamination Certificate
active
10317034
ABSTRACT:
This invention pertains to agonists that activate nuclear receptors. These agonists include an extension that contacts a region of the nuclear receptor outside the native ligand binding pocket. Methods for producing, identifying and designing such agonists are included along with nuclear receptor agonist complexes and libraries of agonists.
REFERENCES:
patent: 5883294 (1999-03-01), Scanlan et al.
patent: 6107517 (2000-08-01), Scanlan et al.
patent: 6236946 (2001-05-01), Scanlan et al.
patent: 6266622 (2001-07-01), Scanlan et al.
patent: 6410245 (2002-06-01), Northrop et al.
patent: 6639078 (2003-10-01), Haffner et al.
patent: 6689574 (2004-02-01), Cummings et al.
patent: 2002/0037514 (2002-03-01), Klein et al.
patent: 2002/0137794 (2002-09-01), Evans et al.
patent: 99/50658 (1999-10-01), None
Baxter, J.D. et al. J of Steroid Biochemistry & Molecular Biology (Mar. 2001) 76 :31.
Webb et al. (2003) J of Steroid Biochem & mol. Biol. 83:59.
Chiellini et al., “Synthesis and Biological Activity of Novel Thyroid Hormone Analogues: 5′-Aryl Substituted GC-1 Derivatives”,Bioorganic&Medicinal Chemistry, (2002) vol. 10:333-346.
Yen (2001) “Physiological and Molecular Basis of Thyroid Hormone Action”Physiological Reviews81(3):1097-1142.
Bourguet et al. (1995) “Crystal Structure of the ligand binding domain of the human nuclear receptor RXR-alpha”Nature375:377-382.
Renaud et al. (1995) “Crystal Structure of the RAR-gamma ligand binding domain bound to all-trans retinoic acid”;Nature378:681-689.
Wagner et al. (1995) “A structural Role for hormone in the thyroid hormone receptor”Nature378:690-697.
Brzozowski et al. (1997) “Molecular Basis of Agonism and Antagonism in the Oestrogen Receptor”Nature389:753-758.
Darimont et al. (1998) “Structure and Specificity of Nuclear Receptor-Coactivator Interactions.”Genes Dev12:3343-3356.
Feng et al. (1998) “Hormone Dependent Coactivator Binding to a Hydrophobic Cleft on Nuclear Receptors”Science280:1747-1749.
Marimuthu et al (2002) “Thyroid Hormone Receptor Surfaces and Conformations Required to Bind Nuclear Receptor Corepressor (N-CoR)”Mol Endocrinol16:271-86.
Shibata et al. (1997)Recent Progress in Hormone Res. 52:141-164.
Tagami, et al. (1997) “Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone.”Mol. Cell Biol. 17(5):2642-2648.
Zhu et al. (1997) “The Differential Hormone-dependent Transcriptional Activation of Thyroid Hormone Receptor Isoforms Is Mediated by Interplay of Their Domains”J. Biol. Chem. 272(14):9048-9054.
Lin et al. (1997) “A conformational switch in nuclear hormone receptor is involved in coupling hormone binding to corepressor release.”Mol. Cell Biol. 17(10):6131-6138.
Kakizawa et al. (1997) “Ligand-dependent heterodimerization of thyroid hormone receptor and retinoid X receptor.”J. Biol. Chem. 272(38):23799-23804.
Chang, K. H., et al. (1997) “A thyroid hormone receptor coactivator negatively regulated by the retinoblastoma protein.”Proc. Natl. Acad. Sci. USA94(17):9040-9045.
Wijayaratne et al (1999) “Comparative analyses of mechanistic differences among antiestrogens.”Endocrinology140(12):5828-5840.
Chang, C.Y., et al (1999) “Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta.”Mol. Cell Biol19(12):8226-8239.
Norris et al (1999) “Peptide Antagonists of the Human Estrogen Receptor”Science285:744-746.
Paige et al (1999) “Estrogen receptor (ER) modulators each induce distinct conformational changes in ER α and ER β”Proc. Natl. Acad. Sci. USA96:3999-4004.
Baxter John D.
Borngraeber Sabine
Fetterick Robert J.
Scanlan Thomas S.
Webb Paul
Littlepage Paul
Quine I.P. Law Group
The Regents of the University of California
Zeman Mary K.
LandOfFree
Method for creating specific, high affinity nuclear receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for creating specific, high affinity nuclear receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for creating specific, high affinity nuclear receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3845396